Your browser doesn't support javascript.
loading
Quantifying the effectiveness of betaherpesvirus-vectored transmissible vaccines.
Varrelman, Tanner J; Remien, Christopher H; Basinski, Andrew J; Gorman, Shelley; Redwood, Alec; Nuismer, Scott L.
Afiliación
  • Varrelman TJ; Bioinformatics and Computational Biology, University of Idaho, Moscow, ID 83844; varr3316@vandals.uidaho.edu.
  • Remien CH; Department of Mathematics and Statistical Science, University of Idaho, Moscow, ID 83844.
  • Basinski AJ; Department of Mathematics and Statistical Science, University of Idaho, Moscow, ID 83844.
  • Gorman S; Telethon Kids Institute, University of Western Australia, 6009 Perth, WA, Australia.
  • Redwood A; School of Biomedical Sciences, University of Western Australia, 6009 Crawley, WA, Australia.
  • Nuismer SL; Institute of Respiratory Health, The University of Western Australia, 6009 Nedlands, WA, Australia.
Proc Natl Acad Sci U S A ; 119(4)2022 01 25.
Article en En | MEDLINE | ID: mdl-35046024
ABSTRACT
Transmissible vaccines have the potential to revolutionize how zoonotic pathogens are controlled within wildlife reservoirs. A key challenge that must be overcome is identifying viral vectors that can rapidly spread immunity through a reservoir population. Because they are broadly distributed taxonomically, species specific, and stable to genetic manipulation, betaherpesviruses are leading candidates for use as transmissible vaccine vectors. Here we evaluate the likely effectiveness of betaherpesvirus-vectored transmissible vaccines by developing and parameterizing a mathematical model using data from captive and free-living mouse populations infected with murine cytomegalovirus (MCMV). Simulations of our parameterized model demonstrate rapid and effective control for a range of pathogens, with pathogen elimination frequently occurring within a year of vaccine introduction. Our results also suggest, however, that the effectiveness of transmissible vaccines may vary across reservoir populations and with respect to the specific vector strain used to construct the vaccine.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 Problema de salud: 1_doencas_transmissiveis Asunto principal: Vacunas / Betaherpesvirinae / Inmunogenicidad Vacunal / Vectores Genéticos / Vacunación Basada en Ácidos Nucleicos / Modelos Teóricos Tipo de estudio: Prevalence_studies / Prognostic_studies / Risk_factors_studies Límite: Animals Idioma: En Revista: Proc Natl Acad Sci U S A Año: 2022 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 Problema de salud: 1_doencas_transmissiveis Asunto principal: Vacunas / Betaherpesvirinae / Inmunogenicidad Vacunal / Vectores Genéticos / Vacunación Basada en Ácidos Nucleicos / Modelos Teóricos Tipo de estudio: Prevalence_studies / Prognostic_studies / Risk_factors_studies Límite: Animals Idioma: En Revista: Proc Natl Acad Sci U S A Año: 2022 Tipo del documento: Article
...